Intuitive Surgical sees FY23 procedure growth up 12%-16%

Sees FY23 gross margins 68%-69%. Sees FY23 operating expense up 9%-13%. Sees FY23 tax rate 22%-24%. Says expects operating margin to fluctuate in next coming quarters. Says expects balanced growth and operating expenses in 2023. Says expects significant increase in expenses related to clinical trial in 2023. Sees FY23 capital expenditures $800M-$1B. Says expects appreciation expense to increase in 2023 and increase more significantly in 2024. Comments and guidance taken from Q4 earnings conference call.